BioNTech to Build Africa’s First mRNA Manufacturing Facility
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
Address: 1, Friesland Drive,
Longmeadow Business Estate,
Modderfontein, 1645,
South Afri,South Africa
Tel: +27 11 372 5000
Web: http://www.merck.co.za/en/index.html;jsessionid=3908AB8A572B0943DE66A547ED859FFF
Merck (Pty) Ltd South Africawho take care of sales, distribution and technical support of a broad range of pharmaceutical, consumer health care and chemical products. The company prides itself on having had representatives in South Africa for more than 100 years and have been registered as an entity in their own right for more than 40 years. The local company has inherited its values from the parent in Germany. These values; ‘Courage’, ‘Respect’, ‘Responsibility’, ‘Integrity’, ‘Transparency’ and ‘Achievement’ are the foundation and substance of everything they do.
Merck is a global pharmaceutical and chemical enterprise with around 40,000 employees in 67 countries. With the acquisition of Millipore in July 2010, a global leader in the life science tools market, revenues totaled around EUR 9.3 billion in 2010.
The Pharmaceuticals business sector comprises innovative prescription drugs as well as over-the-counter products. The Chemicals business sector offers specialty products for the electronics, printing, coatings, cosmetics, food, pharmaceutical and biotech industries.
The operational business is managed under the umbrella of Merck KGaA headquartered in Darmstadt (Germany). Around 30% of the company’s total capital is publicly traded, while the Merck family owns an interest of about 70% via the general partner E. Merck KG.
Merck is the world’s oldest pharmaceutical and chemical company – its roots date back to 1668.
Pharmaceuticals
Merck Serono: Oncology, neurodegenerative diseases, fertility, endocrinology, autoimmune and inflammatory diseases, CardioMetabolic Care
Consumer Health Care: Everyday health protection, mobility, women’s and children’s health, cough and cold
Chemicals
Merck Millipore: Protein research assays and reagents, cell culture solutions and drug discovery services for biopharmaceutical companies as well as laboratory chemicals for research, analytical and hospital laboratories
Performance Materials: Liquid crystals for displays used in televisions, PCs and consumer electronics. LED and OLED materials for display, lighting, and photovoltaics, active ingredients as well as pigments for the cosmetics, paints and coatings industries
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization (WHO) has recommended that the RTS,S malaria vaccine be rolled out across…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and Entos Pharma’s approval for Phase II clinical rials…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and France – has intervened to loan South African…
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in international financial aid, Adcock Ingram’s disappointing results as fewer…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed commercial manufacture of their COVID-19 vaccine candidate, Ad26.COV2-S, boosting the company’s share…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
See our Cookie Privacy Policy Here
